Mangoceuticals, Inc.
MGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,789 | $4,457 | $61,260 | $59,860 |
| - Cash | $59 | $739 | $683 | $23 |
| + Debt | $215 | $129 | $353 | $39 |
| Enterprise Value | $4,945 | $3,847 | $60,930 | $59,877 |
| Revenue | $616 | $731 | $9 | $0 |
| % Growth | -15.8% | 8,083.2% | – | – |
| Gross Profit | $380 | $432 | $5 | $0 |
| % Margin | 61.7% | 59% | 54.3% | – |
| EBITDA | -$7,962 | -$8,094 | -$1,988 | -$18 |
| % Margin | -1,292.8% | -1,106.4% | -22,236.5% | – |
| Net Income | -$8,706 | -$9,212 | -$1,998 | -$18 |
| % Margin | -1,413.6% | -1,259.4% | -22,352.1% | – |
| EPS Diluted | -4.399 | -8.58 | -1.731 | -0.018 |
| % Growth | 48.7% | -395.7% | -9,679.1% | – |
| Operating Cash Flow | -$4,864 | -$6,997 | -$1,347 | -$18 |
| Capital Expenditures | $0 | -$4 | -$43 | $0 |
| Free Cash Flow | -$4,864 | -$7,001 | -$1,390 | -$18 |